BIOMARIN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of BMRN for the last quarter is 10.74 B MXN, and it's 2.06% lower compared to the previous quarter. The net income of Q1 24 is 1.47 B MXN.